Multiple Sclerosis Clinical Trial

Clinical Trial Finder Multiple Sclerosis Trials

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

See Locations Near You

Summary

The purpose of this study is to assess the safety and effectiveness of botulinum toxin type A in treating overactive bladder in spinal cord injury or multiple sclerosis patients

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Urinary incontinence as a result of neurogenic overactive bladder due to spinal cord injury or multiple sclerosis
Inadequate response to anticholinergic medication used to treat overactive bladder

Exclusion Criteria:

History or evidence of pelvic or urologic abnormality
Previous or current diagnosis of bladder or prostate cancer
Urinary tract infection at time of enrollment

Study is for people with:

Multiple Sclerosis

Phase:

Phase 3

Estimated Enrollment:

275

Study ID:

NCT00461292

Recruitment Status:

Completed

Sponsor:

Allergan

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You


Middlebury Connecticut, , United States

Rio de Janeiro , , Brazil

Victoria British Columbia, , Canada

Salouel , , France

Milan , , Italy

Amsterdam , , Netherlands

Porto , , Portugal

Singapore , , Singapore

Pretoria , , South Africa

Tenerife , , Spain

Hualien , , Taiwan

Scunthorpe , , United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Phase:

Phase 3

Estimated Enrollment:

275

Study ID:

NCT00461292

Recruitment Status:

Completed

Sponsor:


Allergan

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider